Galmed Pharmaceuticals Announces Proposed Offering of Ordinary Shares
TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is commencing an underwritten public offering of its…
Comments Off on Galmed Pharmaceuticals Announces Proposed Offering of Ordinary Shares